{"pmid":32348627,"title":"Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.","text":["Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.","From November 2019 to date, almost six thousand papers have been published on COVID-19, the disease caused by SARS-CoV-2 infection. As physicians working in a multidisciplinary centre for the cure of Hereditary Haemorrhagic Telangiectasia (HHT) in a country (Italy) that has been severely affected by COVID-19, we are surprised that, among this impressive amount of publications, there is none on HHT. Indeed, we performed our last PubMed search on 22 April 2020, using the keywords \"Hereditary Haemorrhagic Telangiectasia\" OR \"Hereditary Hemorrhagic Telangiectasia\" OR \"HHT\" OR \"Rendu-Osler-Weber\" AND \"COVID-19\" OR \"coronavirus\", and found no papers. This is surprising, because, although HHT is a rare disease, there are many reasons why we believe that it deserves special attention during the COVID-19 pandemic.","J Thromb Haemost","Gaetani, Eleonora","Cesare Passali, Giulio","Elena Riccioni, Maria","Tortora, Annalisa","Pola, Roberto","Costamagna, Guido","Gasbarrini, Antonio","32348627"],"abstract":["From November 2019 to date, almost six thousand papers have been published on COVID-19, the disease caused by SARS-CoV-2 infection. As physicians working in a multidisciplinary centre for the cure of Hereditary Haemorrhagic Telangiectasia (HHT) in a country (Italy) that has been severely affected by COVID-19, we are surprised that, among this impressive amount of publications, there is none on HHT. Indeed, we performed our last PubMed search on 22 April 2020, using the keywords \"Hereditary Haemorrhagic Telangiectasia\" OR \"Hereditary Hemorrhagic Telangiectasia\" OR \"HHT\" OR \"Rendu-Osler-Weber\" AND \"COVID-19\" OR \"coronavirus\", and found no papers. This is surprising, because, although HHT is a rare disease, there are many reasons why we believe that it deserves special attention during the COVID-19 pandemic."],"journal":"J Thromb Haemost","authors":["Gaetani, Eleonora","Cesare Passali, Giulio","Elena Riccioni, Maria","Tortora, Annalisa","Pola, Roberto","Costamagna, Guido","Gasbarrini, Antonio"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348627","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/jth.14885","keywords":["anticoagulation","bleeding","covid-19","hereditary hemorrhagic telangiectasia","thrombosis"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1665441658221625344,"score":8.599203,"similar":[{"pmid":32219814,"title":"[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].","text":["[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].","Since December 2019, a series of highly infectious cases of unexplained pneumonia have been discovered in Wuhan, Hubei Province, which have been confirmed as '2019 corona virus disease' caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus can invade many human systems including the lungs. Patients with central nervous system involvement may show a series of neurological symptoms, which is easy to be misdiagnosed and neglected, thereby increasing the risk of SARS-CoV-2 transmission. Hereditary ataxia is a large group of neurodegenerative diseases with great clinical and genetic heterogeneity and high mortality and disability. In view of the seriousness of the COVID-19 epidemic, a series of prevention and control measures adopted by the government have restricted the follow-up, diagnosis and treatment of patients by the hospitals, which has a great impact on their mental and physical health. In order to standardize the management of patients during the prevention and control of COVID-19 epidemic, the Specialized Committee of Neurogenetics of the Neurophysician Branch of Chinese Medical Doctor Association has formulated this consensus, with an aim to help patients to overcome the difficulties and pass the epidemic prevention period safely.","Zhonghua Yi Xue Yi Chuan Xue Za Zhi","Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association","Jiang, Hong","Tang, Beisha","32219814"],"abstract":["Since December 2019, a series of highly infectious cases of unexplained pneumonia have been discovered in Wuhan, Hubei Province, which have been confirmed as '2019 corona virus disease' caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus can invade many human systems including the lungs. Patients with central nervous system involvement may show a series of neurological symptoms, which is easy to be misdiagnosed and neglected, thereby increasing the risk of SARS-CoV-2 transmission. Hereditary ataxia is a large group of neurodegenerative diseases with great clinical and genetic heterogeneity and high mortality and disability. In view of the seriousness of the COVID-19 epidemic, a series of prevention and control measures adopted by the government have restricted the follow-up, diagnosis and treatment of patients by the hospitals, which has a great impact on their mental and physical health. In order to standardize the management of patients during the prevention and control of COVID-19 epidemic, the Specialized Committee of Neurogenetics of the Neurophysician Branch of Chinese Medical Doctor Association has formulated this consensus, with an aim to help patients to overcome the difficulties and pass the epidemic prevention period safely."],"journal":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi","authors":["Specialized Committee Of Neurogenetics Neurophysician Branch Of Chinese Medical Doctor Association","Jiang, Hong","Tang, Beisha"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219814","week":"202013|Mar 23 - Mar 29","doi":"10.3760/cma.j.issn.1003-9406.2020.04.001","source":"PubMed","topics":["Treatment","Diagnosis","Prevention","Mechanism"],"weight":1,"locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638742918332416,"score":228.5169},{"pmid":32322822,"pmcid":"PMC7174985","title":"THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC.","text":["THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC.","In the recent months, the world was taken by surprise by the outbreak of a coronavirus (SARS-CoV-2) pandemic (COVID-19). The COVID-19 pandemic is a unique opportunity to advance the understanding of the association of respiratory viruses with mood disorders and suicide. In this editorial, we explore three insights to the neuropsychoneuroimmunology of mood disorders that could be taken from the COVID-19 pandemic.","Brain Behav Immun Health","Brietzke, Elisa","Magee, Taylor","Freire, Rafael C R","Gomes, Fabiano A","Milev, Roumen","32322822"],"abstract":["In the recent months, the world was taken by surprise by the outbreak of a coronavirus (SARS-CoV-2) pandemic (COVID-19). The COVID-19 pandemic is a unique opportunity to advance the understanding of the association of respiratory viruses with mood disorders and suicide. In this editorial, we explore three insights to the neuropsychoneuroimmunology of mood disorders that could be taken from the COVID-19 pandemic."],"journal":"Brain Behav Immun Health","authors":["Brietzke, Elisa","Magee, Taylor","Freire, Rafael C R","Gomes, Fabiano A","Milev, Roumen"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322822","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.bbih.2020.100076","keywords":["aging","covid-19","coronavirus","immunosenesce","mood disorders","suicide"],"source":"PubMed","weight":0,"_version_":1664895932642099200,"score":139.08344},{"pmid":32308536,"pmcid":"PMC7153689","title":"A Critical Appraisal of COVID-19 in Malaysia and Beyond.","text":["A Critical Appraisal of COVID-19 in Malaysia and Beyond.","When the first report of COVID-19 appeared in December 2019 from Wuhan, China, the world unknowingly perceived this as another flu-like illness. Many were surprised at the extreme steps that China had subsequently taken to seal Wuhan from the rest of the world. However, by February 2020, the SARS-CoV-2 virus, which causes COVID-19, had spread so quickly across the globe that the World Health Organization officially declared COVID-19 a pandemic. COVID-19 is not the first pandemic the world has seen, so what makes it so unique in Malaysia, is discussed to avoid a future coronacoma.","Malays J Med Sci","Abdullah, Jafri Malin","Wan Ismail, Wan Faisham Nu'man","Mohamad, Irfan","Ab Razak, Asrenee","Harun, Azian","Musa, Kamarul Imran","Lee, Yeong Yeh","32308536"],"abstract":["When the first report of COVID-19 appeared in December 2019 from Wuhan, China, the world unknowingly perceived this as another flu-like illness. Many were surprised at the extreme steps that China had subsequently taken to seal Wuhan from the rest of the world. However, by February 2020, the SARS-CoV-2 virus, which causes COVID-19, had spread so quickly across the globe that the World Health Organization officially declared COVID-19 a pandemic. COVID-19 is not the first pandemic the world has seen, so what makes it so unique in Malaysia, is discussed to avoid a future coronacoma."],"journal":"Malays J Med Sci","authors":["Abdullah, Jafri Malin","Wan Ismail, Wan Faisham Nu'man","Mohamad, Irfan","Ab Razak, Asrenee","Harun, Azian","Musa, Kamarul Imran","Lee, Yeong Yeh"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32308536","week":"202017|Apr 20 - Apr 26","doi":"10.21315/mjms2020.27.2.1","keywords":["covid-19","malaysia","sars-cov-2","appraisal","medicine","technology"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","China","China","Wuhan","Malaysia","Malaysia","Beyond"],"countries":["Malaysia","China"],"countries_codes":["MYS|Malaysia","CHN|China"],"_version_":1664632501321072640,"score":136.11032},{"pmid":32329044,"title":"Neurological complications of coronavirus and COVID-19.","text":["Neurological complications of coronavirus and COVID-19.","INTRODUCTION: Clinical and experimental studies have shown that the coronavirus family has a certain tropism for the central nervous system. Seven types of coronavirus can infect humans. DEVELOPMENT: Coronaviruses are not always confined to the respiratory tract, and under certain conditions they can invade the central nervous system and cause neurological pathologies. The potential for neuroinvasion is well documented in most human coronaviruses (OC-43, 229E, MERS and SARS) and in some animal coronaviruses (porcine haemagglutinating encephalomyelitis coronavirus). Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well as cases of encephalopathy, encephalitis, necrotising haemorrhagic encephalopathy, stroke, epileptic seizures, rhabdomyolysis and Guillain-Barre syndrome, associated with SARS-CoV-2 infection. CONCLUSIONS: Future epidemiological studies and case records should elucidate the real incidence of these neurological complications, their pathogenic mechanisms and their therapeutic options.","Rev Neurol","Carod-Artal, F J","32329044"],"abstract":["INTRODUCTION: Clinical and experimental studies have shown that the coronavirus family has a certain tropism for the central nervous system. Seven types of coronavirus can infect humans. DEVELOPMENT: Coronaviruses are not always confined to the respiratory tract, and under certain conditions they can invade the central nervous system and cause neurological pathologies. The potential for neuroinvasion is well documented in most human coronaviruses (OC-43, 229E, MERS and SARS) and in some animal coronaviruses (porcine haemagglutinating encephalomyelitis coronavirus). Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well as cases of encephalopathy, encephalitis, necrotising haemorrhagic encephalopathy, stroke, epileptic seizures, rhabdomyolysis and Guillain-Barre syndrome, associated with SARS-CoV-2 infection. CONCLUSIONS: Future epidemiological studies and case records should elucidate the real incidence of these neurological complications, their pathogenic mechanisms and their therapeutic options."],"journal":"Rev Neurol","authors":["Carod-Artal, F J"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329044","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.33588/rn.7009.2020179","topics":["Diagnosis","Treatment","Mechanism"],"weight":1,"_version_":1665420537511280640,"score":129.05191},{"pmid":32202343,"title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","text":["Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.","AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare.","Acta Paediatr","Ludvigsson, Jonas F","32202343"],"abstract":["AIM: The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. METHODS: A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. RESULTS: The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. CONCLUSIONS: The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare."],"journal":"Acta Paediatr","authors":["Ludvigsson, Jonas F"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202343","week":"202013|Mar 23 - Mar 29","doi":"10.1111/apa.15270","keywords":["2019-ncov","covid-19","sars-cov2","children","coronavirus","newborn"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1664639760388325376,"score":122.543045}]}